CB2 cannabinoid receptor agonists: Pain relief without psychoactive effects?

Current Opinion in Pharmacology

Volumn 3, Issue 1, 2003, Pages 62-67

  Malan Jr , T Philip ^a   Ibrahim, Mohab M ^a   Lai, Josephine ^b   Vanderah, Todd W ^a   Makriyannis, Alexandros ^c   Porreca, Frank ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 (4 MORPHOLINYL)ETHYL) 2 METHYL 3 (4 BROMO 1 NAPHYL CARBONYL) 7 METHOXYINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CODEINE; DRONABINOL; GW 403833; INDOLE DERIVATIVE; LEVONANTRADOL; UNCLASSIFIED DRUG; ANALGESIC AGENT; CANNABINOID; CANNABINOID RECEPTOR; DRUG RECEPTOR; PSYCHOTROPIC AGENT;

ANALGESIA; ANTINOCICEPTION; ANXIETY; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC PAIN; DOSE RESPONSE; DRUG ABUSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; DRUG SELECTIVITY; DRUG TARGETING; HUMAN; INFLAMMATION; NEUROPATHY; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; SEDATION; ANIMAL; DRUG POTENTIATION; METABOLISM;

ANALGESICS; ANIMALS; CANNABINOIDS; HUMANS; PAIN; PSYCHOTROPIC DRUGS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0037302086     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(02)00004-8     Document Type: Review

References (43)

1. Iversen L, Chapman V: Cannabinoids: a real prospect for pain relief? Curr Opin Pharmacol 2002, 2:50-55.
2. Campbell FA, Tramar MR, Carroll D, Reynolds JM, Moore RA, McQuay HJ: Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 2001, 323:1-6.
3. Noyes R Jr, Brunk SF, Baram DA, Canter A: Analgesic effect of delta-9-tetra hydocannabinol. J Clin Pharmacol 1975, 15:139-143.
4. Calignano A, La Rana G, Giuffrida A, Piomelli D: Control of pain initiation by endogenous cannabinoids. Nature 1998, 394:277-281.
5. Richardson JD, Aanonsen L, Hargreaves KM: Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB, receptors. Pain 1998, 75:111-119.
6. 2 cannabinoid receptor-mediated peripheral antinociception. Pain 2001, 93:239-245.
7. Munro S, Thomas KL, Abu-Shaar M: Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
8. 1 receptor knockout mice. Proc Natl Acad Sci USA 1999, 96:5780-5785.
9. 2 receptor. Eur J Pharmacol 2000, 396:141-149.
10. Calignano A, La Rana G, Giuffrida A, Pionelli D: Antinociceptive activity of the endogenous fatty acid amide, palmitoylethanolamide. Eur J Pharmacol 2001, 419:191-198.
11. Mazzari S, Canella R, Petrelli L, Marcolongo G, Leon A: N-(2-hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol 1996, 300:227-236.
12. Farquhar-Smith WP, Rice AS: Administration of endocannabinoids prevents a reffered hyperalgesia associated with inflammation of the urinary bladder. Anesthesiology 2001, 94:507-513.
13. 2): Identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 1996, 278:989-999.
14. Lambert DM, DiPaolo FG, Sonveaux P, Kanyonyo M, Govaerts SJ, Hermans E, Bueb J, Delzenne NM, Tschirhart EJ: Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoids receptors. Biochim Biophys Acta 1999, 1440: 266-274.
15. Lambert DM, DiMarzo V: The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic? Curr Med Chem 1999, 6:757-773.
16. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC: Characterization and localization of cannbinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991, 11:563-583.
17. Martin WJ, Patrick SL, Coffin PO, Tsou K, Walker JM: An examination of the central sites of action on cannabinoid-induced antinociception in the rat. Life Sci 1995, 56:2103-2109.
18. 1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
19. Hohmann AG, Herkenham M: Cannabinoid receptors undergo axonal flow in sensory nerves. Neuroscience 1999, 92:1171-1175.
20. Hohmann AG, Herkenham M: Pre- and postsynaptic distribution of cannabinoid and mu opiod receptors in rat spinal cord. Brain Res 1999, 822:17-25.
21. 2 receptor absence in the rat central nervous system. Eur J Pharmacol 1999, 377:117-125.
22. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, LeFur G, Casellas P: Expresson of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulaitons. Eur J Biochem 1995, 232:54-61.
23. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A: Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 1995, 92:3376-3380.
24. 2 receptors. Mol Pharmacol 1995, 48:443-450.
25. Bayewitch M, Avidor-Reiss R, Levy R, Barg J, Mechoulam R, Vogel Z: The peripheral cannabinoid receptor: adenylate cyclase inhibition of G protein coupling. FEBS Letts 1995, 375:143-147.
26. Bouboula M, Rinaldi M, Carayon P, Carillon C, Delpech B, Shire D, Le Fur G, Casellas P: Cannabinoid-receptor expression in human leukocytes. Eur J Biochem 1993, 214:173-180.
27. Wartmann M, Campbell D, Subramanian A, Burstein SH, Davis RJ: The MAP kinase signal transcution pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett 1995, 359:133-136.
28. 2 a peripheral cannabinoid receptor Proc Natl Acad Sci USA 1999, 96:14228-14233.
29. 2 cannabinoid receptor agonist AM1241. American Society of Anesthesiologists Annual Meeting Abstracts 2001, A-894.
30. 2 cannabinoid receptor activation releives acute, tonic and neuropathic pain. American Society of Anesthesilogists Annual Meeting Abstracts 2001, A-978.
31. 2 receptor-mediated suppression of hypersensitivity in the rats with persistent inflammation. Society for Neuroscience Annual Meeting Abstracts 2001, 716.4.
32. 2 receptor agonist, relieves neuropathic pain. Society for Neuroscience Annual Meeting Abstracts 2001, 716.16.
33. 2 cannabinoid receptors: Abstracts of the Tenth World Congress on Pain, International Association for the Study of Pain 2002, 1169.
34. Price TJ, Dussor GD, Hangreaves KM, Flores CM: Expression and distribution of cannabinoid receptor subtypes in trigeminal ganglion: colocalization with nociceptive markers. Society for Neuroscience Annual Meeting Abstracts 2001, 716.13.
35. Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J: Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 1994, 62:327-331.
36. McMahon SB, Bennetth DL, Priestly JV, Shelton DL: The biological effects of endogenous nerve factor on adult sensory neurons revealed by a trkA-lgG fusion molecule. Nat Med 1995, 1:774-70.
37. Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A: Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 1996, 19:514-520.
38. Verge VM, Richardson PM, Wiesenfeld-Hallin Z, Hokfelt T: Differential influence of nerve growth factor on neuropeptide expresson in vivo: a novel role in peptide suppression in adult sensory neurons. Neuroscience 1995, 15:2081-2096.
39. Bennett DL, French J, Priestley JV, McMahon SB: NGF but not NT-3 or BDNF prevents the A fiber sprouting into lamina II of the spinal cord that occurs following axotomy: Mol Cell Neurosci 1996, 8:211-220.
40. Daemen MA, Kurvers HA, Kitslaar PJ, Slaaf DW, Bullens PH, Van den Wildenberg FA: Neurogenic inflammation in an animal model of neuropathic pain. Neurol Res 1998, 20:41-45.
41. Daemen M, Kurvers H, Bullens P, Barendse G, Van Kleef M, Van den Wildenberg F: Neurogenic inflammation and reflex sympathetic dystrophy (in vivo and in vitro assessement in an experimental model). Acta Orthop Belg 1998, 64:441-447.
42. 2 receptors are implicated in inflammatory pain. Pain 2002, 96:253-260.
43. 2 cannabinoid receptors. Chem Phys Lipids 2002, in press.